GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BBS-Bioactive Bone Substitutes PLC (OHEL:BONEH) » Definitions » Net Margin %

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Net Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BBS-Bioactive Bone Substitutes Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. BBS-Bioactive Bone Substitutes's Net Income for the six months ended in Jun. 2024 was €-1.71 Mil. BBS-Bioactive Bone Substitutes's Revenue for the six months ended in Jun. 2024 was €0.00 Mil. Therefore, BBS-Bioactive Bone Substitutes's net margin for the quarter that ended in Jun. 2024 was 0.00%.

The historical rank and industry rank for BBS-Bioactive Bone Substitutes's Net Margin % or its related term are showing as below:


OHEL:BONEH's Net Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.185
* Ranked among companies with meaningful Net Margin % only.

BBS-Bioactive Bone Substitutes Net Margin % Historical Data

The historical data trend for BBS-Bioactive Bone Substitutes's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BBS-Bioactive Bone Substitutes Net Margin % Chart

BBS-Bioactive Bone Substitutes Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only - - - - -

BBS-Bioactive Bone Substitutes Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BBS-Bioactive Bone Substitutes's Net Margin %

For the Medical Devices subindustry, BBS-Bioactive Bone Substitutes's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BBS-Bioactive Bone Substitutes's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BBS-Bioactive Bone Substitutes's Net Margin % distribution charts can be found below:

* The bar in red indicates where BBS-Bioactive Bone Substitutes's Net Margin % falls into.


;
;

BBS-Bioactive Bone Substitutes Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

BBS-Bioactive Bone Substitutes's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-3.484/0
= %

BBS-Bioactive Bone Substitutes's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin=Net Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-1.714/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BBS-Bioactive Bone Substitutes  (OHEL:BONEH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


BBS-Bioactive Bone Substitutes Net Margin % Related Terms

Thank you for viewing the detailed overview of BBS-Bioactive Bone Substitutes's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BBS-Bioactive Bone Substitutes Business Description

Traded in Other Exchanges
N/A
Address
Kiviharjunlenkki 6, Oulu, FIN, 90220
BBS-Bioactive Bone Substitutes PLC is a Finnish health technology company, that develops, designs and manufactures inventive bioactive bone-graft substitute implants. Its bioactive implants provide clinical and financial benefits for the treatment of patients with bone defects and healing problems.

BBS-Bioactive Bone Substitutes Headlines

No Headlines